Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study
Titel:
Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study
Auteur:
Jelinek, Tomas Cromer, Michael A. Cramer, Jakob P. Mills, Deborah J. Lessans, Kenneth Gherardin, Anthony W. Barnett, Elizabeth D. Hagmann, Stefan H.F. Askling, Helena H. Kiermayr, Sigrid Kadlecek, Vera Eder-Lingelbach, Susanne Taucher, Christian Dubischar, Katrin L.